Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/04/17 → 2/04/22 |
MM19: A Phase 3 trial of thalidomide-dexamethasone consolidation versus thalidomide-dexamethasoneIxazomib consolidation for transplant eligible multiple myeloma patients undergoing a single ASCT as part of front-line therapy
- Spencer, Andrew (Primary Chief Investigator (PCI))
Project: Research